TrialBritish journal of clinical pharmacology2013

Safety, tolerability and pharmacokinetics of a human anti-interleukin-13 monoclonal antibody (CNTO 5825) in an ascending single-dose first-in-human study.

Bart van Hartingsveldt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.